Venmax Drugs

Not Rated

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE154G01022
NSEID:
BSEID: 531015

INR

28.48

-0.58 (-2.0%)

BSENSE

Apr 11, 12:34 PM

BSE+NSE Vol: 62

Click here to access the older version

Cash Flow

Venmax Drugs Cash flow Statement

Figures in Rs cr

Standaloned Cash Flow Results

Mar'22

Mar'21

Mar'20

Mar'19

Mar'18

Mar'17

Compare Cash Flow Results of Venmax Drugs

Select Peers

Figures in Rs cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

1.85

2259.57

-2,258.00

-99.92%

Adjustment

0.01

161.91

-161.00

-99.99%

Changes In working Capital

0.05

-40.95

40.00

100.12%

Cash Flow after changes in Working Capital

1.91

2380.53

-2,379.00

-99.92%

Cash Flow from Operating Activities

1.91

1982.97

-1,981.00

-99.90%

Cash Flow from Investing Activities

-1919.22

1,919.00

100.00%

Cash Flow from Financing Activities

-1.98

-8.68

7.00

77.19%

Net Cash Inflow / Outflow

-0.07

55.07

-55.00

-100.13%

Opening Cash & Cash Equivalents

0.08

134.13

-134.00

-99.94%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

189.2

-189.00

-100.00%

Cash Flow - Snapshot (Standalone) - Mar'22

YoY Growth in year ended Mar 2022 is 634.62% vs 192.86% in Mar 2021

Mar'22

Mar'21

Change(%)

Cash Flow from Operating Activities

1.91

0.26

634.62%